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ABSTRACT 
Background: It is our opinion that amaranth seed oil’s properties merit further study due to 
their high quantity of squalene. Squalene has been shown to have antitoxic, antioxidant, and 
hepatotropic properties. The liver is one of the most important organs in the human body, 
and as a filtering organ, it is subjected to many toxic compounds and free radicals. Thus, 
protecting  the  liver  with  an  antioxidant  and  antitoxic  compound  could  offer  significant 
benefits.  
 
Objective:  In  the  present  study  we  have  evaluated  the  antitoxic,  antioxidant,  and 
hepatotropic  (hepatoprotective)  effects  of  amaranth  oil  acquired  via  a  patented  pressing 
method.  Rats  were  treated  with  amaranth  oil,  a  comparative  compound,  or  a  control 
compound and then subjected to various toxic, oxidizing, and other compounds in order to 
examine amaranth oil’s effects.   
 
Results: Amaranth oil was found to have a positive and dose-dependent effect both in vivo 
and in vitro. Amaranth oil’s hepatoprotective activity was confirmed by both biological and 
morphological  examination.  This  study  suggests  that  amaranth  oil  acts  to  prevent  and 
reduce CT damage in liver tissue. This was especially the case in doses of 300 mg/kg, 
proved  both  by  normalization  of  hepatic  ferments-markers  indexes  and  morphological 
examinations. 
 
Conclusion: The amaranth oil acquired via a patented pressing method possesses antitoxic 
and antioxidant activity.   In this connection, the amaranth oil can be recommended for 
prophylaxis of toxic and drug-induced liver lesions and as a component of the functional 
food and dietetics of various diseases. 
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BACKGROUND 
The liver is one of the major organs of the gastrointestinal tract in the human organism. 
From a functional and morphological perspective, it is highly sensitive to the damaging 
activity of chemical compounds. All toxic compounds, whether they be products of amino 
acids  metabolism  (phenol,  cresol,  skatole,  etc.);  products  of  intestinal  micro  flora  vital 
activity; or exogenous xenobiotics coming from the gastrointestinal tract, they first enter the 
liver, which is considered to be a key organ of metabolism. Quite often in a process of 
xenobiotics  biotransformation,  intermediate  and  highly  reactive  metabolites  are  formed, 
which are able to enter in numerous chemical reactions [11, 15]. 
According to the World Health Organization, data for the last decades all over the 
world shows a notable amplification of liver disease. More than 2 billion people worldwide 
suffer from pathology of the hepatobiliary system, making liver disease 100 times more 
prevalent than HIV. It has been documented that one of the major etiological factors of liver 
pathology  is  the  presence  of  toxic  lesions  of  the  liver  tissue,  often  due  to  alcohol  and 
medicine.  
The main objective of both the treatment of liver illnesses and that of the complications 
they  cause  is  the  elimination  of  etiological  factors  and  the  main  pathogenetic  disease 
mechanisms. The ultimate goal of treatment is to restore full liver function and morphology 
[10]. 
In light of the fact that one of the universal mechanisms of cell damage is oxidation of 
membranous  structures  mediated  by  the  intensified  production  of  the  reactive  oxygen 
species, it is sensible to use antioxidant agents to help treat and prevent liver disease. For 
this  purpose,  vitamins  E,  A,  and  C,  as  well  as  the  antioxidant  enzyme  of  superoxide 
dismutase, can be applied as hepatoprotectors. This leads to an inhibition of the lipid per 
oxidation  (LP)  processes,  stabilizing  the  hepatocyte  membranes  and  accelerating  the 
reparative processes in the liver [1, 3]. Along with this, one of the pathogenetic mechanisms 
of  liver  damage  is  ischemia,  which  can  enhance  the  free-radical  oxidation  process  in 
hepatocytes [8]. In studying both compounds, which possess hepatotropic properties and 
which can be used to treat liver disease, it is important to consider compounds which can 
act both in an antioxidant and antihypoxic manners. It is also especially useful to consider 
the potential effects of herbal drugs, which can have benefits in both activity latitude and 
length of application [1].  
In our opinion, one important compound to consider is amaranth oil (Amaranth L.), 
which contains extraordinarily high levels of squalene (to 8%). This can be compared with 
olive oil, which only has 0.7%. The main source of squalene at the moment is the livers of 
abyssal  sharks  (the  content  reaches  from  60  to  90%),  which  produce  it  as  an  adaptive 
response  to  the  hypoxic  requirements  arising  from  floating  in  major  depths  [5,  12]. 
Squalene is one of the most powerful protectors against free radicals activity. In addition, it 
carries out a role in lipid and steroid metabolism and regulation in an organism, as well as 
regulation of cholesterol and vitamin D metabolism [2, 7].  
In addition, the composition of amaranth oil includes such antioxidants like vitamins E 
and  A.  Vitamin  E  is  estimated  to  have  an  intensive  antioxidant  activity  in  the  cell 
membrane, which can help to stabilize and protect the cell from oxidation damage, aid in 
immunodefence,  act  in  an  anti-carcinogenic  manner,  and  retard  aging.  In  amaranth  oil, 
vitamin E is present in its most biologically active trienoic form in levels that reach 1% [2, Functional Foods in Health and Disease 2014; 4(5):159- 171                                                     Page 161 of 171 
6, 12]. Vitamin A participates in the oxidation and reduction processes as well as protein 
synthesis, and it promotes normal metabolism and cell membrane functions [2, 4, 12].  
The  content  of  polynonsaturated  fatty  acids  like  Omega-3,  which  act  as  building 
materials  for  cells  of  the  human  body,  reaches  51%.  Phosphotides  (up  to  10%),  which 
consist predominately of phosphatidylcholine (lecithin), are a constituent of cytoplasmic 
cell membranes, promote structure restoration, substitute defects of the damaged lipid layer 
in biological membranes, and recover its physicochemical properties [1, 6, 14]. 
In  the  present  study  we  have  evaluated  antitoxic,  antioxidant,  and  hepatotropic 
(hepatoprotective) effects of amaranth oil acquired by a patented pressing method [16].  
 
MATERIALS AND METHODS 
The experiments were performed on male non-linear white rats (n=74) weighing 180-250 g 
and male non-linear pubertal mice weighing 18-22 g, according to protocols approved by 
the  “Rules of Work Operation with Experimental Animals” (the appendix to the order of  
USSR  Public  Health  Ministry,  №  755,  12.  08.1977).  All  animals  lived  in  standard 
conditions of the vivarium of the Voronezh state medical academy named after by N.N. 
Burdenko. 
As  the  background  for  hepatoprotective  activity  investigation,  we  first  studied  the 
antitoxic and antioxidant activity of amaranth oil. 
Using  male  non-linear  pubertal  white  rats  (n=14,  m=220-230  g),  we  tested  the 
amaranth oil antitoxic activity in the “hexenalum sleep” test. According to the experimental 
purposes and tasks, all animals were divided into 3 groups: intact (n=5), experimental (n=4), 
and  control  (n=5).  Rats  of  the  experimental  group  were  injected  subcutaneously  with 
amaranth oil with a single dose of 600mg/kg (in recalculation on phosphotides), each 24 
hours before the Hexenalum introduction. As a comparison, the drug Essentiale (produced 
by Sanofi-Aventis) was chosen. It contains essential phosphatides derived from soybean oil 
and is used widely as a reference hepatoprotector. Essentiale officinal solution was given as 
a  single  dose  each  to  the  control  group  animals  subcutaneously,  24  hours  before  the 
Hexenalum introduction (in a dose of 0.085 mg/kg). Animals of the intact group received an 
equivalent  quantity  of  water  perorally.  Hexenalum  test  was  performed  according  to  a 
procedure described in the Management on the experimental preclinical research of new 
pharmacological  substances  [13]  and  procedures  described  by  V.V.  Gatsura  (1974). 
Hexenalum  was  introduced  in  a  single  dose  in  the  form  of  a  4.0%  water  solution.  An 
intraperitoneal injection was given in a 60 mg/kg dose, which is equal to 0.35 ml/300 g of a 
rat  body.  Doses  in  recalculation  on  solution  milliliters  were  counted  individually 
considering animal body mass. As efficiency criterion the duration of sleep invoked by 
Hexenalum was estimated. The duration of sleep was registered for each animal in group by 
stop watch. 
The drug was determined to be actively antitoxic active if it provided a reduction of 
sleep duration in comparison with the intact group of animals.  
Antioxidant activity was estimated by influence on structurally functional properties of 
erythrocytes  membranes  (in  vitro)  and  lifetime  of  laboratory  animals  under  the  acute 
hypoxia with hypercapnia (in vivo).  
In experiments in vitro, a procedure of acid erythrogram recording was used. These 
studies required blood erythrocytes of 30 pubertal white non-linear male rats weighing 180-
250 g. Animals were divided on 6 groups (n=5 in each). Animals of the first control group Functional Foods in Health and Disease 2014; 4(5):159- 171                                                     Page 162 of 171 
received a physiological solution of Sodium chloride. Animals of the second, third, and 
fourth groups were injected with amaranth oil in doses of 300 mg/kg, 600 mg/kg, and 1200 
mg/kg (in recalculation on phosphotides), respectively. The fifth experimental group was 
each injected with a drug of comparison (Essentiale) in the form of officinal solution (in a 
dose of 80 mg/kg). The animals of the sixth group received an equivalent quantity of water. 
Drugs were introduced only once (single-dosing) into the stomach by metal gastric tube one 
day before the erythrogram registration. To model the liver lesion (acute toxic hepatitis 
model), an intraperitoneal injection of carbon tetrachloride (CT, CCl4) was performed (in a 
dose of 0.4 ml/kg, in the form of a 50% olive oil solution) one hour before the blood 
sampling (except in control group animals) [13]. 
Blood was taken through the caudal veins of anesthetized animals by a resection of the 
tail tip. Blood gravity flow was collected in the tube with 0.1 ml of Heparinum (5000 Units 
in 1 ml) per 1-1.5 ml of blood. Erythrocyte suspension was received via 10 minutes of 
centrifugation at a rate of 3000 rpm, and further extraction of supernatant fluid after triply 
washing under the same conditions. The hemolysis was induced by 0.1 M hydrochloric 
acid. The kinetics of erythrocytes hemolysis was assessed by the spectrophotometer. 
Following  parameters  were  used  to  characterize  the  acid  erythrocyte  resistance:  a 
constant of the hemolysis peak rate (Kmax, relative units.); value Gsph of erythrocytes (%) 
characterizing the relative part of cells in a spherulation stage; tlat - time reflecting a stage of 
erythrocytes hemolysis latency (seconds); and G50 - level of 50 % of a hemolysis (%). 
Assessment of oil influence on the laboratory animals’ lifetime under acute hypoxia 
with hypercapnia required 70 non-linear pubertal male mice weighing of 18-22 g. Animals 
were divided on 7 groups (10 each). The first group was intact. The second, third, and 
fourth group served as control and each received a single dosing of L- thyroxin (0.5 ml) in 
stomach (5, 10, and 20 mkg, respectively) 2 hours before the examination. The fifth, sixth, 
and seventh group of animals received amaranth oil preliminarily (within 3 days in doses of 
20 mg in recalculation on phosphotides) perorally, 3 times a day. On the 4th day, animals of 
the control and experimental groups (groups №2-7) took 0.5 ml of L-thyroxin perorally (in 
a dose of 5, 10, and 20 mkg, respectively). The bottleneck was pressurized (V.V.Gatsura, 
1974). The time from the moment of hermetic sealing of container up to the last appreciable 
respiratory locomotion was registered. 
A logarithmic graphic chart was made on the dependence of surviving duration on the 
examinee substance dose after the end of experiment. 
To  test  the  oil’s  hepatoprotective  activity,  a  model  of  experimental  toxic  hepatitis 
(ETH) was used. Experiments were performed on 30 white non-linear male rats of the same 
age in masses ranging 180-250 g preliminarily, fasting during 18-20 h. 
Animals  were  divided  on  6  groups  (n=5  each).  The  first  group  consisted  of  intact 
animals, the second was taken as a control and received distilled water. Animals of the 
third, fourth, and fifth groups were introduced with amaranth oil one day before the ETH 
modeling in doses of 300 mg/kg, 600 mg/kg, and 1200 mg/kg, respectively. Procedures 
were executed one time via a metal gastric tube.  Animals of the sixth group received a drug 
of comparison, Essentiale, which was introduced in the form of officinal solution into the 
stomach in a dose of 80 mg/kg according via a similar regimen. To simulate toxic hepatitis, 
animals were unitary hypodermically injected with CT in the form of a 50% solution on 
peachy oil in a dose of 0.4 ml on 100 g animal body mass [13]. Functional Foods in Health and Disease 2014; 4(5):159- 171                                                     Page 163 of 171 
During ETH modeling, the mortality of animals was not observed. The sheme and CT 
dose used are sufficient for making a valuable biochemical pattern of the liver parenchyma 
toxic  lesion  and  also  give  the  chance  to  follow  the  direction  of  induced  pathological 
process. Rats were decapitated under chloroformic anesthesia.  
Development of ETH was confirmed using biochemical and morphological research 
techniques. For biochemical spectrophotometric examinations, the serum was used. It was 
received  by  centrifugation  of  whole  blood  during  15  min  at  rate  of  3000  rpm.  For 
morphological examination, the tissue samples of a hepatic lobe (3×3×2 mm) were taken 
and fixed in 10% neutral formalin solution. Paraffin sections (4-5 microns in thickness) 
were imbued with hematoxylin and eosine. Filming of tissue specimens was carried out by 
means of the fixed USB-chamber in a Levenhuk 8 Mpixel microscope.  
Data  were  analyzed  using  Student's  test  (with P <  0.05  as  the  threshold  for 
significance). All values are expressed as means ± SD.  Statistical software suitable for 
biology and medicine were used for calculations. 
 
RESULTS 
The obtained results show that the mean duration of hexenalum sleep in animals of the 
intact  group  was  56.6±12.6  minutes  (Table  1).  The  drug  of  comparison,  Essentiale, 
provided a considerably significant reduction of sleep duration of 45.6% compared with 
intact  group.  In  addition  to  that,  under  the  influence  of  amaranth  oil,  the  duration  of 
hexenalum sleep decreased to 32.0% compared with intact group. Thus differences with 
Essentiale efficiency were 13.6%. 
 
Table  1.  Duration  of  hexenalum  sleep  in  experimental  animals  after  amaranth  oil 
application 
 
Index 
 
Intact group 
(n=5) 
Experimental 
group (n=4) 
Control group 
(n=5) 
Duration of sleep, 
minutes 
56, 6 ±12.6  38.5±5.0  30.8±6.6* 
Difference with intact 
group, % 
-  32.0%  45.6% 
Note: * р≤0.05.  
 
Effects of amaranth oil influences on indexes of acid erythrograms are shown in table 2.  
Analysis of acid hemolysis peak rate constant value (Кmax), which characterizes a part 
of erythrocytes population that simultaneously enters into a stage of the hemolysis proper, 
has shown that unitary intraperitoneal CT introduction in a dose of 0.4 ml/kg 1 hour before 
the erythrogram recording was accompanied by a reliable augmentation of hemolysis rate 
among the erythrocytes of average-resistant population by 40.3% compared to the control 
group.  The  rate  of  erythrocyte  hemolysis  in  the  basic  average-resistant  population  at 
preliminary amaranth oil introduction in doses of 300 mg/kg, 600 mg/kg, and 1200 mg/kg, 
and Essentiale in a dose of 80 mg/kg did not  differ from  control indexes significantly. 
However, it is necessary to notice that amaranth oil introduction on average promoted the 
Кmax reduction concerning control on 23.1%, 9.0%, and 23.8%, respectively. In case of 
Essentiale application, the erythrocytes simultaneously entering into a stage of hemolysis Functional Foods in Health and Disease 2014; 4(5):159- 171                                                     Page 164 of 171 
proper was a little higher (on 1.9%) compared with erythrocytes of animals in the group that 
did not receive the substance explored.  
 
Table 2.  Changes of erythrocytes acid hemolysis indexes in acute toxic hepatitis model 
under amaranth oil application 
 
Name  Kmax, relative units  Gsph, %  tlat, sec  G50,% 
Control, 0,9 %   
NaCl solution 
5.78±0.93  -2.60±1.3  125.0±45.3  256.70±37.9 
Amaranth oil in 
a dose of 300 
mg/kg 
4.45±0.23**  -1.25±0.95*  65.0±31.2*  235.0±8.7* 
Amaranth oil in 
a dose of 600 
mg/kg 
5.26±0.97  -1.20±1.22*  105.0±30.0**  246.70±15.3** 
Amaranth oil in 
a dose of 1200 
mg/kg 
4.40±0.71**  -2.65±0.3**  105.0±21.2**  230.0±40.0* 
Essentiale in a 
dose of 80 
mg/kg 
5.89±0.37**  -0.48±1.1**  80.0±48.2*  228.3±2.9* 
CT, CCl4  8.11±0.0005*  -0.45±0.096*  50.0±17.3**  205.0±8.7* 
Note: * - р≤0.01; ** - р≤0.05. 
 
Value  of  Gsph  index  reflecting  the  relative  part  of  spherocytes,  at  amaranth  oil 
introduction in doses of 300 mg/kg, 600 mg/kg, and 1200 mg/kg, did not differ from the 
control  level  reliably.  However,  in  doses  of  300  mg/kg  and  600  mg/kg,  the  part  of 
spherocytes on average values was half as much as the control. In a dose of 1200 mg/kg, it 
was almost peer to intact level. After Essentiale introduction in a dose of 80 mg/kg, the 
tendency to Gsph reduction was expressed more to what the reduction of part of erythrocytes 
simultaneously  being  in  a  spherocytosis  stage  on  81.5%  compared  control.  After  CT 
introduction, Gsph rate was significantly below the control level (on 82.7 %, р <0.05). From 
this fact we considered that preliminary introduction of amaranth oil and Essentiale retards 
the stage of the hemolysis development and approximates it to the indexes of the control 
groupTlat  of  acid  hemolysis,  reflecting  the  hemolysis  latency  stage  duration,  after 
intraperitoneal  introduction  of  CT  in  a  dose  of  0.4  ml/kg.  It  was  accompanied  by  the 
shortening of hemolysis latent time by 60% compared to the control group. Tlat   lead-acid 
hemolysis with the use of amaranth oil in doses of 300 mg / kg, 600 mg/kg, 1200 mg/kg, 
and Essentiale in a dose of 80 mg/kg reliably did not differ from the control.  
The  analysis  of  time  of  50%  of  hemolysis  occurrence  (G50,%)  shows  that  CT 
introduction invoked G50 reduction on 20.1% compared with the control. The amaranth oil 
and Essentiale retarded development of erythrocyte hemolysis of the basic average-resistant 
population concerning indexes of animals with CCl4-invoked hepatitis.  It has  found the 
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600 mg/kg, and 1200 mg/kg and Essentiale in a dose of 80 mg/kg before CT application the 
studied index value reliably did not differ from those in control group. 
 The analysis of antioxidant activity investigation results on the hypoxia model testified 
that L-thyroxin in doses of 5, 10, and 20 mkg invoked reduction of lifetime in control group 
of rats compared intact group by 21.5%, 31.4%, and 34.5%, respectively (р <0,05). Along 
with this, the preliminary amaranth oil administration in a dose of 20 mg (perorally during 3 
days) prolonged the lifetime in experimental group in relation to the control by 9.7% and 
14.7%, respectively (at р <0.05) on the background of L-thyroxin - invoked hypoxia (Table 
3).  
 
Table 3.  Degree of experimental animals’ resistance to hypoxia with hypercapnia with 
amaranth oil application 
Group of animals  Time of animals 
death, minutes 
   M±m 
Reduction of animals 
lifetime, % 
Compared 
intact group 
Compared 
control group 
Intact group  131.70±15.5  -  - 
L-thyroxin, 5 mkg  103.40±5.6  78.5  - 
L-thyroxin, 10 mkg  90.40±6.68  68.6  - 
L- thyroxin, 20 mkg  86.20±8.04  65.5  - 
Peroral introduction of amaranth oil 
L- thyroxin, 5 mkg  113.50±3.5  86.2  109.7 
L- thyroxin, 10 mkg  103.70±6.7  78.7  114.7 
L- thyroxin, 20 mkg  84.50±5.1  64.2  - 
 
Hepatoprotective activity examination after unitary introduction of CT in experimental 
animals showed development of toxic liver lesions. This was proved by the rising of alanin 
aminotranspherases (AlAT) and aspartate aminotransferases (AsAT), which are estimated to 
be the ferments-markers of hepatic cytolysis in relation to datum level on 143% and 83.5% 
(р <0.05), respectively. Likewise the increasing of total bilirubin level on 59.2% was recorded 
in blood serum. It was estimated as signs of erythrocytolysis and haemoglobin destruction 
or disturbance in system of conjugated bilirubin transmission from a hepatic cell into bile.  
Along with this, liver toxic lesion development was confirmed by the augmentation of 
whole hexoses by 19.46 % (that specifies on inflammation development); the reduction of free 
SH-groups by 9.3% (obviously bound to depression of peroxidases activity); and finally rise 
of malonic dialdehyde concentration compared initial quantity by 25 %, which shows activation 
of lipid peroxide oxidation and degradation of polynonsaturated fats by the reactive oxygen 
spices.  
Unitar Essentiale introduction in a dose of 80 mg/kg invoked in rats the reduction of AsAT and AlAT activity 
almost to a level in the control group (by 64.5 % and 52.2 %, respectively); and augmentation of  total bilirubin  in 
blood serum by 13 % compared with the control and reduction of whole hexoses by 22.5 %.  
Unitary introduction of amaranth oil in doses of 300 mg/kg, 600 mg/kg, and 1200 mg/kg against the 
background of ETH decreased AlAT activity in relation to control on 18%, 44.7%, and 68.7%, respectively; 
suppressed AsAT activity by 19.3% (in the dose of 600 mg/kg) and 35.5% (in the  dose of 1200 mg/kg); reduced Functional Foods in Health and Disease 2014; 4(5):159- 171                                                     Page 166 of 171 
concentration of whole hexoses by 11.8%, 24.7%, and 19%, respectively. Dynamics  of  biochemical 
indexes under the ETH are presented in Table 4. 
 
Table 4: Change of biochemical indexes in rat blood serum under the experimental 
toxic hepatitis on the background of amaranth oil application 
Note: * - р <0.05; ** - р <0.01 
 
In  a  morphological  pattern  in  all  areas  of  liver  tissue  lobules,  lymphohistiocytic 
infiltration was revealed except the expressed fatty degeneration of liver.  
The portal tract veins hyperemia with leukostasis in it, as well as reduction of glycogen 
level, were noted. 
At an assessment of the structural organization of the livers of the intact group of rats, it 
was established that the functional activity of the livers of those rats was in limens of the 
physiological norm, the architectonics and structure of hepatic lobules were without visible 
changes, changes in interlobular connective tissue were absent (figure 1 a), and the lobule 
girder  structure  was  of  the  norm  (figure  1  c).  In  the  perivascular  region,  individual 
centrolobular hepatocytes were hypertrophied and extensive vacuolation of liver cells was 
observed around the central vein, as well as on the periphery. Individual hepatocytes were 
in a karyopyknosis and karyolysis state. Close-grained fatty degeneration was noted. The 
Blood serum 
Malonic 
dialdehyd,  
mcM/l 
AsAT, 
mkKAT/l 
AlAT, 
mkKAT/l 
Coefficient 
AsAT / 
AlAT 
Total bilirubin, 
mcM/l 
Whole 
hexoses 
(g/l) 
Free SH-groups, 
mg % 
Intact group 
 
2.0 ±0.6 
 
0.51±0.2 
 
0.73±0.2 
 
-1.43 
 
2.16±0.75  
 
1.49±0.16 
 
134.72±4.61 
Control group (toxic hepatitis model) 
 
2.5±0.04 
 
1.24±0.23 
 
1.34±0.44 
 
-1.08 
 
3.44±1.7 
 
1.78±0.05 
 
122.15±1.73 
Essentiale 0.085 mg/kg 
 
2.0±0.01* 
 
0.8±0.2* 
 
0.7±0.17** 
 
1.14 
 
3.89±1.3 
 
1.38±0.03* 
 
134.21±5.33* 
Amaranth oil, 300 mg/kg 
 
2.1±0.02 
 
1.25±0.23 
 
1.1±0.21* 
 
1.16 
 
5.48±2.04** 
 
1.57±0.18 
 
130.10±8.8* 
Amaranth oil, 600 mg/kg 
 
1.5±0.02** 
 
1.0±0.1* 
 
0.74±0.08* 
 
1.38 
 
4.76±1.05** 
 
1.34±0.34** 
 
134.79±5.74* 
Amaranth oil, 1200 mg/kg 
 
1.4±0.02** 
 
0.8±0.2* 
 
0.42±0.2** 
 
2.09 
 
4.76±1.8* 
 
1.44±0.17* 
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cytoplasma was light and foamy. The central vein contains inappreciable quantities of blood 
corpuscles (figure 1 d). Centrolobular localisation of damages (figure 1 b, c) prevails.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. The histologic specimen of a rat liver of intact group. Colorated with 
hematoxylin-eosine. Augmentation: a- × 10; b, c, d, - × 40                
 
Upon microscopic examination of histologic sections of rats’ liver in the control group 
(toxic hepatitis model), the de-condensation of the venous blood vessel walls and the strong 
cytoplasma clarification around the central vein were observed (Figure 2 a, b), and the 
blood vessel intima had grown coarse (Figure 2).  
 
a  b 
c  d 
            
Figure 2. The histologic specimen of a rat liver of control group (ETH). Colorated with 
hematoxylin-eosine. Augmentation: a − ￗ 10; b, c, d - × 40. 
a  b 
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Loss of the girder structure of hepatic lobules, a balloon dystrophia of cells,  and a 
karyolysis  and  a  karyopyknosis  of  hepatocytes  around  the  central  vein  were  registered. 
There were also necrobiotic fields. Individual hepatocytes were strongly vacuolated with 
nucleus reduction (Figure 2 а-d). Also, disturbances were observed in the field of the central 
vein  and  on  peripheric  fields.  The  character  of  the  established  hepatic  tissue  structure 
disturbances  and  rising  of  ferments-markers  of  hepatic  cytolysis  activity  (ALAT  and 
ASAT) corresponded to the changes descending at toxic hepatitis development. 
Preliminary  Essentiale  introduction  in  a  dose  of  80  mg/kg  before  CT  introduction 
testifies to regenerative activity in the field of the central vein, which is proved by presence 
of the binuclear and hypertrophied hepatocytes on sections. However, the maintenance of 
vacuolated hepatocytes on the periphery was noted (Figure 3 c, d). Both the architectonics 
of hepatic lobules and the structure of lobules were without visible changes. There was 
insignificant de-condensation of interlobular connective tissue. The girder structure of a 
lobule was expressed weakly (Figure 3 a). The presence of a balloon dystrophia and traces 
of necrotic changes with centrolobular localization (Figure 3 b) were registered. The central 
vein contained the inappreciable blood corpuscle quantities.  
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Figure 3. The histologic specimen of a rat liver with ETH under Essentiale application in 
dose of 80 mg/kg. Colorated with hematoxylin-eosine. Augmentation: a, c - × 10; b, d - × 40. 
 
The  amaranth  oil  application  in  a  dose  of  300  mg/kg  normalized  the  structural 
organization of a liver, as well as prevented signs of necrosis, dystrophia, inflammatory 
responses,  and  any  other  damages.  Architectonics  of  hepatic  lobules  were  normal  as 
structure of lobules and changes of interlobular connective tissue were absent. Individual 
vacuolated hepatocytes and fatty incorporations (Figure 4 a) remained. The expressed signs 
of regeneration activity confirmed by diffusely located functionally active hepatocytes and 
appreciable augmentation of binuclear cells (Figure 3 b) were observed. In the livers of the 
animals, receiving amaranth oil preliminary in a dose of 600 mg/kg caused similar changes Functional Foods in Health and Disease 2014; 4(5):159- 171                                                     Page 169 of 171 
at morphological examination of microscopic sections. However in this group the individual 
blood corpuscles in the central vein were present (Figure 4 c, d).  
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Figure 4. The histologic specimen of a rat liver at ETH under amaranth oil application in 
dose of 300 mg/kg. Colorated with hematoxylin-eosine. Augmentation: a - × 10; b - × 40. 
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Figure 5. The histologic specimen of a rat liver at ETH under amaranth oil application in 
dose of 600 mg/kg.Colorated with hematoxylin-eosine. Augmentation: a - 10; b - × 40. 
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Figure 6. The histologic specimen of a rat liver at ETH and amaranth oil application in dose 
of 1200 mg/kg. Colorated with hematoxylin-eosine. Augmentation: a, b - × 10; c, d - × 40. Functional Foods in Health and Disease 2014; 4(5):159- 171                                                     Page 170 of 171 
In the group of the animals preliminary treated with  an intragastric introduction of 
amaranth oil in a dose of 1200 mg/kg, morphological loss of the liver parenchyma girder 
structure and intensive de-condensation and growth of interlobular connective tissue around 
the liver portal tracts (Figure 6 a, b) were observed. Thus, the architectonics of hepatic 
lobules was of the norm. The karyolysis and karyopyknosis phenomena and presence of 
cirrhotic fields were found. Both the centrolobular hepatocytes and peripheric cells (Figure 
6,  b-d)  were  damaged.  This  can  testify  to  the  dose-dependent  effect  of  amaranth  oil 
application. 
 
DISCUSSION 
Along with the aforementioned considerations, it is worth noting the effects of xenobiotics 
on  the  liver.  Xenobiotics  influence  the  activity  of  the  monooxygenase  enzyme  system, 
whose  key  point  is  the  family  of  cytochromes  Р450,  which  carry  out  a  catabolism  of 
endogenous  biologically  active  substances  and  xenobiotics.  Depression  of  Р-450 
complicates pharmacotherapy essentially and also leads to ekzo - an endotoxin resistance 
reduction and dysfunction of humoral regulatory mechanisms [9]. Now the drugs boosting 
the liver antitoxic function and interfering inactivation of Р-450 cytochromes are estimated 
as  used  widely  on  liver  toxic  lesions  [1].  Using  the  hexenalum  sleep  model,  we  have 
reliably proved ability of amaranth oil to decrease the barbiturates-invoked narcotic sleep 
duration. The changes established argue to presence of amaranth oil’s antitoxic activity and 
most probably characterize its ability to be the hepatocyte microsomal fermentation inducer 
of the cytochrome Р450 system.  
Based on the results of the in vitro experiments, it is possible to come to the conclusion 
that CT invokes damage of a cytoplasmic membrane of the basic population of erythrocytes 
(at the specified way and introduction dose). It can be bound to augmentation of oxidative 
processes  in  a  cell’s  membrane.  Preliminary  Essentiale  and  amaranth  oil  introduction 
promotes a weakening of the CT damaging activity, which is probably due to the anti-
oxidant properties of these pharmacological active substances.  This is consistent with the 
observation  that  the  phenomenon  is  realized  due  to  the  increasing  of  membranes’ 
permeability threshold for hydrogen ions compared separate CT application.  
On the animals’ survival rate model, it is posited that the preliminary introduction of 
amaranth oil protects an organism against hypoxia invoked by L-thyroxin introduction in 
doses  of  5,  10,  and  20  mkg,  which  probably  leads  to  boosting  L-thyroxin  influence 
reduction on thyroid gland function. 
Amaranth oil hepatoprotective activity is confirmed by the results of biochemical and 
morphological examinations. This study implicates amaranth oil’s preventive appointment 
in reducing the damage of CT in liver tissue. This effect was especially observed in a dose 
of  300  mg/kg,  which  is  proved  both  by  normalization  of  hepatic  fermentation-marker 
indexes and morphological examinations. Effects of oil application in doses of 600 mg/kg 
and 1200 mg/kg testify to a dose-dependent effect developed as a reduction of protective 
action  on  the  background  of  regenerative  processes  in  a  liver  that  is  expressed  by 
displacement of CT toxic activity on peripheric cells.  
 
CONCLUSIONS 
The  amaranth  oil  received  acquired  by  patented  pressing  technology  possessed  the 
expressed antitoxic and anti-oxidant activity. Against a toxic liver lesion, the oil application Functional Foods in Health and Disease 2014; 4(5):159- 171                                                     Page 171 of 171 
intensifies regenerative processes. However, the dose-dependent character of this process is 
worth considering.  
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